Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-25

Clinical Trial Update: Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating intravitreal ranibizumab alone versus ranibizumab with targeted retinal photocoagulation for radiation retinopathy has completed with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranibizumab (ranibizumab)

Snippet

Sponsor: Greater Houston Retina Research | Conditions: Radiation Retinopathy | Phase 2 | Status: COMPLETED | Results posted: 2021-03-25